https://orcid.org/0000-0002-3176-9184
References
- Isaacs H. Fetal and neonatal cardiac tumors. Pediatr Cardiol. 2004;25(3):252–273.
- Yuan SM. Fetal cardiac tumors: clinical features, management and prognosis. J Perinat Med. 2018;46(2):115–121.
- Morka A, Kohut J, Radzymińska-Chruściel B, et al. Echocardiography and newer imaging techniques in diagnosis and long-term follow-up of primary heart tumors in children. Int J Environ Res Public Health. 2020;17(15):5471.
- Isaacs H. Perinatal (fetal and neonatal) tuberous sclerosis: a review. Am J Perinatol. 2009;26(10):755–760.
- Chao AS, Chao A, Wang TH, et al. Outcome of antenatally diagnosed cardiac rhabdomyoma: case series and a meta-analysis. Ultrasound Obstet Gynecol. 2008;31(3):289–295.
- Shaddy RE, Penny DJ, Feltes TF, et al. Moss and adams’ heart disease in infant, children, and adolescent: including the fetus and young adult. 10th ed. Lippincott Williams & Wilkins, a Wolters Kluwer business; 2021.
- Ide T, Miyoshi T, Katsuragi S, et al. Prediction of postnatal arrhythmia in fetuses with cardiac rhabdomyoma. J Matern Fetal Neonatal Med. 2019;32(15):2463–2468.
- Abuhamad A, Chaoui R. A practical guide to fetal echocardiography: normal and abnormal hearts. 3rd ed. Lippincott Williams, Wolters Kluwer; 2016.
- Fesslova V, Villa L, Rizzuti T, et al. Natural history and long-term outcome of cardiac rhabdomyomas detected prenatally. Prenat Diagn. 2004;24(4):241–248.
- Northrup H, Aronow ME, Bebin EM, et al. Updated international tuberous sclerosis complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol. 2021;123:50–66.
- Garg A, Gorla SR, Kardon RE, et al. Involution of large cardiac rhabdomyomas with everolimus therapy. World J Pediatr Congenit Heart Surg. 2021;12(3):426–429.
- Lawley C, Popat H, Wong M, et al. A dramatic response to sirolimus therapy in a premature infant with massive cardiac rhabdomyoma. JACC Case Rep. 2019;1(3):327–331.
- Sugalska M, Tomik A, Jóźwiak S, et al. Treatment of cardiac rhabdomyomas with mTOR inhibitors in children with tuberous sclerosis complex – a systematic review. Int J Environ Res Public Health. 2021;18(9):4907.
- Sagiv E, Chikkabyrappa SM, Conwell J, et al. Use of everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: benefits and complications. Ann Pediatr Cardiol. 2022;15(1):58–60.
- Öztunç F, Atik SU, Güneş AO. Everolimus treatment of a newborn with rhabdomyoma causing severe arrhythmia. Cardiol Young. 2015;25(7):1411–1414.
- Wagner R, Riede FT, Seki H, et al. Oral everolimus for treatment of a giant left ventricular rhabdomyoma in a neonate-rapid tumor regression documented by real time 3D echocardiography. Echocardiography. 2015;32(12):1876–1879.
- Shibata Y, Maruyama H, Hayashi T, et al. Effect and complications of everolimus use for giant cardiac rhabdomyomas with neonatal tuberous sclerosis. AJP Rep. 2019;9(3):e213–7–e217.
- Demir HA, Ekici F, Yazal Erdem A, et al. Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma. Pediatrics. 2012;130(1):e243-247–e247.